Skip to content

Crataegus effect on patients undergoing coronary artery bypass surgery

Effects of Crataegus on cardiovascular parameters of patients undergoing coronary artery bypass graft

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016122025772N5
Enrollment
12
Registered
2017-02-12
Start date
2016-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery bypass graft. Mechanical complication of coronary artery bypass and valve grafts

Interventions

Intervention 1: Intervention group: on the third-day after surgery 30 drops of crataegus, three times a day for one month daily. Intervention 2: Control group: on the third day after surgery 30 drops
Treatment - Drugs
Intervention group: on the third-day after surgery 30 drops of crataegus, three times a day for one month daily.
Control group: on the third day after surgery 30 drops of placebo three times a day for one month daily.

Sponsors

Vice chancellor for Research, Mashhad University of Medical Science
Lead Sponsor
Exir Teb Zakaria company
Collaborator

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: LVEF less than 30%; The minimum age of 40 and maximum age 80 years; techniques Off-pump coronary artery bypass grafting is a method. Exclusion criteria: require any further surgery; comorbidity to valvular disease such as kidney, liver, diabetes and COPD; The risk of serious mental illness; alcohol and drug addiction; BMI> ...

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood pressure. Timepoint: Before intervention,One month after intervention. Method of measurement: Mm Mercury.;Left ventricular ejection fraction. Timepoint: Before intervention, one month after intervention. Method of measurement: Percent.;Exercise tolerance test. Timepoint: Before intervention, one month after intervention. Method of measurement: Minutes.;Malondialdehyde. Timepoint: Before intervention, one month after intervention. Method of measurement: Milli grams per deciliter.;C-reactive protein. Timepoint: Before intervention, one month after intervention. Method of measurement: Milli grams per deciliter.;Total cholestrol. Timepoint: Before intervention, one month after intervention. Method of measurement: Milli grams per deciliter.;LDL. Timepoint: Before intervention, one month after intervention. Method of measurement: Milli grams per deciliter.;VLDL. Timepoint: Before intervention, one month after intervention. Method of measurement: Milli grams per deciliter.;HDL. Timepoint: Before intervention, one month after intervention. Method of measurement: Mill igrams per deciliter.;Triglyceride. Timepoint: Before intervention, one month after intervention. Method of measurement: Milli grams per deciliter.;Fasting blood sugar. Timepoint: Before intervention,One month after intervention. Method of measurement: Milli grams per deciliter.;ALT. Timepoint: Before intervention, one month after intervention. Method of measurement: Milli grams per deciliter.;AST. Timepoint: Before intervention, one month after intervention. Method of measurement: Per liter.;Urea. Timepoint: Before intervention, one month after intervention. Method of measurement: Milli grams per deciliter.;Creatinine. Timepoint: Before intervention, one month after intervention. Method of measurement: Milli grams per deciliter.;Sodium. Timepoint: Before intervention, one month after intervention. Method of measurement: mEq.;Potassium. Timepoint: Before intervention,One month after intervention. Method

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyed Abbas Zojaji

Exir Teb Zakaria Company

exirtebzakaria@gmail.com+98 51 3502 4824

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026